Remarks by US president Donald Trump at the swearing in ceremony of new Health and Human Services (HSS) Secretary Alex Azar confirm his administration’s determination to drastically lower the price of prescription medications in the USA.
Mr Azar’s appointment as head of the US Health and Human Services Department was confirmed by the US Senate last week, and made official at The White House earlier today.
President Trump said Mr Azar was “going to get those prescription drug prices way down as a little bit of an extra,” adding that prices were “going to come rocketing down.”
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze